US Stock MarketDetailed Quotes

RGLS Regulus Therapeutics

Watchlist
  • 1.4900
  • +0.0300+2.05%
Close Nov 1 16:00 ET
97.54MMarket Cap-1241P/E (TTM)

Regulus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regulus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Regulus Therapeutics Earnings Reports

  • Regulus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:30 ET

  • Regulus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 16:32 ET

  • Regulus Therapeutics | 10-K: FY2023 Annual Report

    Mar 21 16:33 ET

  • Regulus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 16:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data